Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
ABT Abbott Laboratories daily Stock Chart
ABT [NYSE]
Abbott Laboratories
Healthcare | Medical Appliances & Equipment | USA
financial highlights | statements
IndexS&P 500 P/E52.96 EPS (ttm)1.32 Insider Own0.20% Shs Outstand1.76B Perf Week-0.79%
Market Cap123.01B Forward P/E21.84 EPS next Y3.20 Insider Trans-16.71% Shs Float1.74B Perf Month2.24%
Income2.33B PEG4.53 EPS next Q0.81 Inst Own75.10% Short Float1.07% Perf Quarter3.43%
Sales30.40B P/S4.05 EPS this Y44.60% Inst Trans-0.10% Short Ratio2.58 Perf Half Y10.62%
Book/sh17.45 P/B4.01 EPS next Y11.03% ROA1.20% Target Price79.47 Perf Year17.36%
Cash/sh4.29 P/C16.29 EPS next 5Y11.68% ROE2.90% 52W Range55.58 - 74.92 Perf YTD-3.35%
Dividend1.28 P/FCF41.56 EPS past 5Y47.40% ROI2.20% 52W High-6.69% Beta1.17
Dividend %1.83% Quick Ratio1.10 Sales past 5Y7.50% Gross Margin58.00% 52W Low25.78% ATR1.83
Employees99000 Current Ratio1.40 Sales Q/Q12.10% Oper. Margin10.20% RSI (14)50.85 Volatility1.84% 2.58%
OptionableYes Debt/Eq0.77 EPS Q/Q4.00% Profit Margin2.90% Rel Volume1.28 Prev Close71.49
ShortableYes LT Debt/Eq0.63 EarningsJan 23 BMO Payout220.30% Avg Volume7.26M Price69.91
Recom1.90 SMA200.76% SMA50-0.57% SMA2006.10% Volume10,196,466 Change-2.21%
Jan-02-19Downgrade Citigroup Neutral → Sell
Nov-30-18Upgrade Goldman Neutral → Buy
Oct-16-18Initiated Barclays Overweight $80
Jun-27-18Initiated Bernstein Outperform $73
Jan-30-18Reiterated Citigroup Neutral $59 → $64
Jan-25-18Upgrade William Blair Mkt Perform → Outperform
Jan-25-18Reiterated Stifel Buy $63 → $71
Jan-03-18Initiated Evercore ISI Outperform
Jan-02-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-02-18Upgrade JP Morgan Neutral → Overweight
Oct-19-17Reiterated Stifel Buy $58 → $63
Oct-19-17Reiterated RBC Capital Mkts Outperform $55 → $60
Oct-06-17Resumed JP Morgan Neutral
Sep-28-17Reiterated Barclays Overweight $57 → $60
Aug-17-17Initiated Citigroup Neutral $53
Jun-29-17Resumed Jefferies Buy
Jun-29-17Initiated Guggenheim Buy $58
Jun-21-17Resumed BTIG Research Buy $56
May-16-17Initiated Goldman Neutral $45
Apr-20-17Reiterated Barclays Overweight $50 → $52
Jan-24-19 02:29AM  Edited Transcript of ABT earnings conference call or presentation 23-Jan-19 2:00pm GMT Thomson Reuters StreetEvents
Jan-23-19 08:21PM  Hedge Fund Hooligans: Cramer's 'Mad Money' Recap (Wednesday 1/23/19) TheStreet.com
04:42PM  Abbott Labs (ABT) Stock Slips Despite Solid Q4 Earnings InvestorPlace
04:15PM  Abbott Slides On Revenue Lag, But Outlook Prods Drug Stocks Investor's Business Daily
04:09PM  Dow Rises as Wall Street Weighs Strong Earnings, Global Growth Concerns TheStreet.com
04:09PM  Abbott Labs Falls After Solid Earnings and Dividend Raise, Revenue Miss TheStreet.com
03:41PM  5 Must-See Stock Charts for Thursday: ABT, IBM, SBUX, PZZA InvestorPlace
02:36PM  Abbott misses revenue estimates, sees lackluster first-qtr profit Reuters
02:04PM  Healthcare ETFs Slip After Abbot Labs Revenue Miss, Weak Outlook ETF Trends
01:27PM  Abbott Laboratories (ABT) Q4 2018 Earnings Conference Call Transcript Motley Fool
10:12AM  US STOCKS-Wall Street bounces back on strong corporate earnings Reuters
10:09AM  Abbott Labs says M&A not a high priority now Reuters
09:11AM  US STOCKS-Wall St set to open higher on strong earnings from Dow members Reuters
09:10AM  [$$] Stocks to Watch: IBM, P&G, Synchrony The Wall Street Journal
09:00AM  Abbott (ABT) Meets Q4 Earnings Estimates Zacks
08:21AM  Abbott stock falls 2.7% after fourth-quarter revenue falls short MarketWatch
08:01AM  Abbott: 4Q Earnings Snapshot Associated Press
08:00AM  Today's Research Reports on Trending Tickers: Abbott Laboratories and Medtronic ACCESSWIRE
07:53AM  Abbott Lab's fourth-quarter revenue rises 2.3 pct Reuters
07:45AM  Abbott Reports 2018 Results and Issues Strong Forecast for 2019 PR Newswire
03:29AM  Stocks - IBM, P&G, United Tech, Comcast Soar in Premarket; Apple Rises Investing.com
02:50AM  Abbott Labs Earnings in Line, Revenue Misses In Q4 Investing.com
12:53AM  Top 5 Things to Know in The Market on Wednesday Investing.com
Jan-22-19 05:26PM  Abbott Laboratories Expected to Earn 81 cents a Share TheStreet.com
01:26PM  Abbott Laboratories Q4 Earnings Preview Benzinga
09:45AM  All Signals Are Positive for Buying Abbott Laboratories InvestorPlace
08:35AM  Medical Product Stocks' Earnings on Jan 23: ABT, NXGN & VAR Zacks
Jan-21-19 09:00AM  Abbott Offers a New Option for Physicians Treating Patients with Atrial Fibrillation PR Newswire
Jan-18-19 06:10PM  Cramer's game plan: This week, forecasts are more important than earnings CNBC
08:44AM  Can Medical Devices Strength Drive Abbott (ABT) Q4 Earnings? Zacks
08:43AM  Is a Surprise Coming for Abbott (ABT) This Earnings Season? Zacks
06:36AM  What Lies Ahead for Abbott (ABT) Stock This Earnings Season? Zacks
Jan-17-19 12:47PM  Here's Yana Barton's 2019 stock picks CNBC Videos
09:00AM  Japanese Red Cross Society Selects Abbott Technology to Screen Country's Blood and Plasma Supply PR Newswire
08:17AM  3 Weight-Loss Stocks in Focus on Rising Obesity Fears Zacks
05:00AM  Top Picks 2019- Abbott Laboratories ABT MoneyShow
Jan-16-19 03:04PM  3 Healthcare Stocks That Will Keep Your Portfolio Healthy InvestorPlace
10:30AM  Abbott (ABT) Earnings Expected to Grow: Should You Buy? Zacks
09:06AM  10 Profit-Rich Stocks for Lean Times Investopedia
09:00AM  Abbott To Acquire Cephea Valve Technologies, Inc. PR Newswire
Jan-15-19 09:30PM  3 Top Diabetes Stocks to Watch in January Motley Fool
10:10AM  Abbott Labs Rises 3% Investing.com
Jan-14-19 05:50PM  Abbott (ABT) Dips More Than Broader Markets: What You Should Know Zacks
09:00AM  FDA Approves World's First Device for Treatment of Premature Babies and Newborns with an Opening in Their Hearts (a Common Congenital Defect) PR Newswire
Jan-11-19 04:14PM  Why This Group Is 'An Attractive Destination For Investors' In 2019 Investor's Business Daily
03:45PM  3 Back-of-the-Shelf Consumer Stocks With Growth and Income InvestorPlace
08:00AM  Abbott and "Malaria No More" Work Together to End Malaria in Odisha, India PR Newswire
Jan-10-19 09:46AM  Zacks Value Trader Highlights: PayPal, Abbott Labs, UnitedHealth, Lam Research and Visa Zacks
07:52AM  Can We See Significant Institutional Ownership On The Abbott Laboratories (NYSE:ABT) Share Register? Simply Wall St.
Jan-09-19 05:14PM  These 5 Companies are Earnings Perfection Zacks
Jan-08-19 06:48AM  Abbott Labs Falls 3% Investing.com
Jan-07-19 05:50PM  Abbott (ABT) Outpaces Stock Market Gains: What You Should Know Zacks
10:56AM  As Patent Expirations Loom, the Clock Is Ticking on AbbVie Stock InvestorPlace
Jan-04-19 04:30PM  [$$] Angel Medical Wins Court Approval to Tap Bankruptcy Loan The Wall Street Journal
07:26AM  3 Big Stock Charts for Friday: Incyte, Schlumberger and Abbott Laboratories InvestorPlace
07:22AM  Abbott Labs Rises 3% Investing.com
Jan-03-19 12:35PM  3 Biopharma Stocks to Buy for Their Robust Dividend Yields InvestorPlace
04:54AM  Abbott Labs Falls 4% Investing.com
Jan-02-19 02:39PM  [$$] Angel Medical Files for Bankruptcy The Wall Street Journal
04:52AM  Abbott Labs Falls 3% Investing.com
Dec-31-18 08:12AM  The Zacks Analyst Blog Highlights: Merck, Abbott, Lockheed Martin, United Parcel Service and Bank of New York Mellon Zacks
Dec-28-18 04:09PM  Will A New Approval Help This Medical Stock Approach A Breakout? Investor's Business Daily
01:49PM  Top Analyst Reports for Merck, Abbott & Lockheed Martin Zacks
Dec-27-18 05:50PM  Abbott (ABT) Outpaces Stock Market Gains: What You Should Know Zacks
01:14PM  Pedialyte targets hungover adults Yahoo Finance Video
Dec-26-18 01:48PM  Abbott Labs Rises 3% Investing.com +6.19%
Dec-24-18 10:10AM  Why Abbott (ABT) Could Beat Earnings Estimates Again Zacks
Dec-21-18 10:26AM  Marlo Thomas, Matthew Morrison and More at Brooks Brothers Annual Holiday Celebration in NYC to Benefit St. Jude LifeMinute.TV Videos
Dec-19-18 03:00PM  Get Bubbly this New Year with Abbott's New Pedialyte® Sparkling Rush Powder Packs PR Newswire
01:49PM  Abbott Laboratories (NYSE:ABT) Insiders Increased Their Holdings Simply Wall St.
Dec-18-18 05:50PM  Abbott (ABT) Outpaces Stock Market Gains: What You Should Know Zacks
08:35AM  5 Beaten-Down Medical Product Stocks to Rebound in 2019 Zacks
Dec-17-18 12:47PM  Abbot Labs to Rise GuruFocus.com
09:40AM  MBIO: Mustang: A Steed on the Fast Track Zacks Small Cap Research
09:20AM  A Solution to the Nation's Current Opioid Overdose Epidemic and The World's Leading Cause of Disability ACCESSWIRE
09:00AM  Abbott Hosts Conference Call for Fourth-Quarter Earnings PR Newswire
Dec-14-18 03:15PM  5 Biggest Medtech Stocks -- Are They Buys? Motley Fool
11:08AM  Abbott Raises Quarterly Dividend 14%, Increasing Payouts for 47 Straight Years PR Newswire
Dec-12-18 08:28PM  [$$] Number of Britons linked to far-right extremism soars Financial Times
05:50PM  Abbott (ABT) Outpaces Stock Market Gains: What You Should Know Zacks
10:51AM  5 Pharma Stocks That Could Cure Ailing Portfolios in 2019 InvestorPlace
Dec-11-18 12:26PM  Shire, Abbott Labs May Pace Healthcare Stocks in 2019 TheStreet.com
09:00AM  Abbott to Present at J.P. Morgan Healthcare Conference PR Newswire
06:57AM  Generic-drug stocks slammed by report of expanded price-fixing probe MarketWatch
Dec-10-18 11:30AM  Generic drug makers stocks fall sharply after report of expanded price-fixing probe MarketWatch
Dec-08-18 10:43AM  Is Abbott Laboratories (ABT) A Good Stock To Buy? Insider Monkey
Dec-07-18 06:46PM  Cramer's lightning round: There are better drug stocks to own than GlaxoSmithKline CNBC
04:12PM  Abbott Labs Falls 3% Investing.com
03:38PM  Most Important Mergers and Acquisitions of 2016 Investopedia
Dec-06-18 06:50AM  Today's Research Reports on Trending Tickers: Boston Scientific and Abbott Laboratories ACCESSWIRE
Dec-04-18 03:28PM  Abbott Labs Falls 3% Investing.com
Dec-03-18 02:25PM  AbbVie Stock Could Become a New Happy Pill for Investors InvestorPlace
Nov-30-18 06:15PM  Abbott Laboratories (ABT) Chairman and CEO Miles D White Sold $10.3 million of Shares GuruFocus.com
05:45PM  Abbott (ABT) Outpaces Stock Market Gains: What You Should Know Zacks
03:26PM  3 Beaten-Down Biotech Stocks to Buy Before the End of 2018 InvestorPlace
07:08AM  Jim Cramer Shares His Thoughts On DowDuPont, Home Depot And More Benzinga
12:00AM  [$$] Vivian Maier: The secret hoard of a suburban spy Financial Times
Nov-29-18 06:47PM  Cramer's lightning round: Buy DowDuPontthe breakup-related pain is over CNBC
Nov-28-18 02:46PM  Abbott Labs Rises 3% Investing.com
Nov-25-18 12:46PM  Spinal-cord stimulators mean big business for device makers Associated Press
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; and anti-infective clarithromycin, as well as provides influenza vaccine and products that regulate physiological rhythm of the colon. Its Diagnostic Products segment offers core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; benchtop systems and rapid tests in the areas of infectious diseases; molecular point-of-care test systems for influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Cardiovascular and Neuromodulation Products segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WHITE MILES DChairman and CEONov 28Option Exercise26.02325,0008,454,8753,459,185Nov 30 05:02 PM
WHITE MILES DChairman and CEONov 28Sale72.585,519400,5823,134,185Nov 30 05:03 PM
WHITE MILES DChairman and CEONov 28Sale72.35142,34110,298,6103,316,844Nov 30 05:02 PM
WHITE MILES DChairman and CEONov 28Sale72.49177,14012,840,5983,139,704Nov 30 05:03 PM
Watkin JaredSenior Vice PresidentNov 02Option Exercise38.4065,0002,496,000128,640Nov 06 05:08 PM
Watkin JaredSenior Vice PresidentNov 02Sale71.0065,0004,615,00063,640Nov 06 05:08 PM
Bracken Sharon JSenior Vice PresidentSep 28Sale73.351,732127,04439,029Oct 02 06:58 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentSep 28Sale73.395,000366,95788,521Oct 02 06:58 PM
Blaser Brian JExecutive Vice PresidentSep 20Option Exercise27.4358,2001,596,165195,018Sep 21 05:02 PM
Blaser Brian JExecutive Vice PresidentSep 20Sale68.7958,2004,003,862136,818Sep 21 05:02 PM
Funck Robert ESenior Vice PresidentSep 05Option Exercise25.2436,400918,727145,080Sep 07 05:15 PM
Contreras JaimeSenior Vice PresidentAug 29Option Exercise37.67172,4686,496,984222,904Aug 31 05:04 PM
Contreras JaimeSenior Vice PresidentAug 29Sale66.8464,2684,295,39554,968Aug 31 05:05 PM
Contreras JaimeSenior Vice PresidentAug 29Sale66.7495,7936,393,590127,111Aug 31 05:04 PM
LANE ANDREW HExecutive Vice PresidentAug 29Sale67.119,097610,51326,583Aug 31 05:03 PM
Bracken Sharon JSenior Vice PresidentJul 30Sale65.1661540,07340,761Jul 31 05:01 PM
CAPEK JOHN MExecutive Vice PresidentJul 25Option Exercise26.0264,9001,688,374363,200Jul 26 05:05 PM
CAPEK JOHN MExecutive Vice PresidentJul 25Sale65.0064,9004,218,500298,300Jul 26 05:05 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 24Sale63.5080350,99178,417Jul 24 05:02 PM
Blaser Brian JExecutive Vice PresidentJul 24Sale63.9615,100965,789136,818Jul 26 05:09 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 23Sale63.2024715,61079,220Jul 24 05:02 PM
Bracken Sharon JSenior Vice PresidentJul 23Sale63.2025916,36941,376Jul 24 05:01 PM
Funck Robert ESenior Vice PresidentJun 05Option Exercise26.0212,800332,992117,293Jun 07 05:08 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMay 18Sale61.501,00061,50094,581May 21 05:16 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMay 17Sale61.052,000122,09295,581May 21 05:16 PM
Bracken Sharon JSenior Vice PresidentMay 04Sale58.562,150125,90942,140May 08 05:00 PM
Contreras JaimeSenior Vice PresidentApr 23Sale59.3684950,3972,595Apr 25 05:12 PM
BIRD ROGERSenior Vice PresidentMar 09Sale62.758,262518,45058,174Mar 13 05:03 PM
Watkin JaredSenior Vice PresidentMar 07Sale61.193,000183,57965,515Mar 09 05:01 PM
Bracken Sharon JSenior Vice PresidentMar 05Sale60.272,100126,55944,290Mar 07 05:11 PM
Fussell Stephen RExecutive Vice PresidentMar 01Sale60.1311,106667,804161,052Mar 02 05:17 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMar 01Sale58.9790553,36997,581Mar 02 05:15 PM
Watkin JaredSenior Vice PresidentMar 01Sale58.8799658,63568,515Mar 02 05:15 PM
MANNING JOSEPH JSenior Vice PresidentMar 01Sale58.981,43084,34438,466Mar 02 05:14 PM
Contreras JaimeSenior Vice PresidentMar 01Sale59.746,284375,38150,436Mar 02 05:13 PM
Funck Robert ESenior Vice PresidentMar 01Sale58.991,22071,970104,493Mar 02 05:11 PM
BIRD ROGERSenior Vice PresidentMar 01Sale58.801,64596,72866,436Mar 02 05:13 PM
Bracken Sharon JSenior Vice PresidentMar 01Sale58.931,05362,05646,390Mar 02 05:09 PM
STARKS DANIEL JDirectorFeb 27Buy60.7729,5541,795,9017,012,839Feb 28 06:35 PM
STARKS DANIEL JDirectorFeb 27Buy60.8740024,3487,013,239Feb 28 06:36 PM
STARKS DANIEL JDirectorFeb 27Buy60.6740,0372,429,2376,983,285Feb 28 06:34 PM
Fussell Stephen RExecutive Vice PresidentFeb 20Option Exercise38.40104,6424,018,253289,526Feb 21 07:23 PM
Watkin JaredSenior Vice PresidentFeb 20Sale59.2929717,60973,377Feb 21 06:21 PM
PEDERSON MICHAEL JSenior Vice PresidentFeb 20Sale59.2945927,21382,069Feb 21 06:18 PM
Fussell Stephen RExecutive Vice PresidentFeb 20Sale59.845,532331,048184,884Feb 21 07:24 PM
Fussell Stephen RExecutive Vice PresidentFeb 20Sale59.6156,4013,361,948233,125Feb 21 07:23 PM
Fussell Stephen RExecutive Vice PresidentFeb 20Sale59.7342,7092,550,813190,416Feb 21 07:23 PM
Blaser Brian JExecutive Vice PresidentJan 31Option Exercise22.3927,733620,995156,587Feb 01 05:50 PM
Fussell Stephen RExecutive Vice PresidentJan 31Sale62.681,00062,680561,518Feb 01 05:48 PM
Blaser Brian JExecutive Vice PresidentJan 31Sale62.2627,7331,726,634128,854Feb 01 05:50 PM
Ford Robert BExecutive Vice PresidentJan 30Option Exercise31.0583,4672,591,776135,633Feb 01 05:47 PM
Fussell Stephen RExecutive Vice PresidentJan 30Option Exercise37.32388,98314,516,345571,121Feb 01 05:48 PM
Fussell Stephen RExecutive Vice PresidentJan 30Sale62.83161,37110,139,045182,338Feb 01 05:48 PM
Ford Robert BExecutive Vice PresidentJan 30Sale62.9842,6652,687,13492,968Feb 01 05:47 PM
Fussell Stephen RExecutive Vice PresidentJan 30Sale62.7729,0501,823,535153,288Feb 01 05:49 PM
Fussell Stephen RExecutive Vice PresidentJan 30Sale62.8413,313836,607139,975Feb 01 05:49 PM
Ford Robert BExecutive Vice PresidentJan 30Sale63.0340,8022,571,62452,166Feb 01 05:47 PM
Fussell Stephen RExecutive Vice PresidentJan 30Sale62.75226,41214,207,000343,709Feb 01 05:48 PM
open in yahoo | open in reuters | open in google